| Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug H Wu, E Esteve, V Tremaroli, MT Khan, R Caesar, L Mannerås-Holm, ... Nature medicine 23 (7), 850-858, 2017 | 1455 | 2017 |
| Insulin resistance and chronic cardiovascular inflammatory syndrome JM Fernández-Real, W Ricart Endocrine reviews 24 (3), 278-301, 2003 | 1410 | 2003 |
| Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance JM Moreno-Navarrete, F Ortega, M Serrano, E Guerra, G Pardo, ... The journal of clinical endocrinology & metabolism 98 (4), E769-E778, 2013 | 968 | 2013 |
| Cross-talk between iron metabolism and diabetes JM Fernández-Real, A López-Bermejo, W Ricart Diabetes 51 (8), 2348-2354, 2002 | 867 | 2002 |
| Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women JM Fernandez-Real, M Vayreda, C Richart, C Gutierrez, M Broch, ... The Journal of Clinical Endocrinology & Metabolism 86 (3), 1154-1159, 2001 | 836 | 2001 |
| Olive oil and health: summary of the II international conference on olive oil and health consensus report, Jaén and Córdoba (Spain) 2008 J López-Miranda, F Pérez-Jiménez, E Ros, R De Caterina, L Badimón, ... Nutrition, metabolism and cardiovascular diseases 20 (4), 284-294, 2010 | 740 | 2010 |
| Physiology and role of irisin in glucose homeostasis N Perakakis, GA Triantafyllou, JM Fernández-Real, JY Huh, KH Park, ... Nature reviews endocrinology 13 (6), 324-337, 2017 | 595 | 2017 |
| Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women L Hoyles, JM Fernández-Real, M Federici, M Serino, J Abbott, ... Nature medicine 24 (7), 1070-1080, 2018 | 593 | 2018 |
| Increase in plasma endotoxin concentrations and the expression of Toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high … H Ghanim, S Abuaysheh, CL Sia, K Korzeniewski, A Chaudhuri, ... Diabetes care 32 (12), 2281-2287, 2009 | 592 | 2009 |
| Dyslipidemia and inflammation: an evolutionary conserved mechanism E Esteve, W Ricart, JM Fernandez-Real Clinical nutrition 24 (1), 16-31, 2005 | 542 | 2005 |
| Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11. 2 locus S Jacquemont, A Reymond, F Zufferey, L Harewood, RG Walters, ... Nature 478 (7367), 97-102, 2011 | 532 | 2011 |
| Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and β-cell function JM Fernández-Real, G Penarroja, A Castro, F García-Bragado, ... Diabetes 51 (4), 1000-1004, 2002 | 492 | 2002 |
| Targeting the circulating microRNA signature of obesity FJ Ortega, JM Mercader, V Catalan, JM Moreno-Navarrete, N Pueyo, ... Clinical chemistry 59 (5), 781-792, 2013 | 474 | 2013 |
| Serum ferritin as a component of the insulin resistance syndrome JM Fernández-Real, W Ricart-Engel, E Arroyo, R Balançá, ... Diabetes care 21 (1), 62-68, 1998 | 438 | 1998 |
| MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation FJ Ortega, JM Moreno-Navarrete, G Pardo, M Sabater, M Hummel, ... PloS one 5 (2), e9022, 2010 | 431 | 2010 |
| Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile TO Kilpeläinen, MC Zillikens, A Stančákova, FM Finucane, JS Ried, ... Nature genetics 43 (8), 753-760, 2011 | 428 | 2011 |
| Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization FJ Ortega, JM Mercader, JM Moreno-Navarrete, O Rovira, E Guerra, ... Diabetes care 37 (5), 1375-1383, 2014 | 409 | 2014 |
| Circulating omentin concentration increases after weight loss JM Moreno-Navarrete, V Catalán, F Ortega, J Gómez-Ambrosi, W Ricart, ... Nutrition & metabolism 7, 1-6, 2010 | 400 | 2010 |
| Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects JM Fernandez-Real, M Broch, J Vendrell Cristóbal Richart, W Ricart The Journal of Clinical Endocrinology & Metabolism 85 (3), 1334-1339, 2000 | 376 | 2000 |
| Serum visfatin increases with progressive β-cell deterioration A Lopez-Bermejo, B Chico-Julia, M Fernandez-Balsells, M Recasens, ... Diabetes 55 (10), 2871-2875, 2006 | 372 | 2006 |
Wifredo RicartInstitut d'investigació Biomèdica de Girona (IDIBGI)在 idibgi.org 的电子邮件经过验证
